Search bioRxiv⌕ Search

Biology subjects

Borbely, S.

Publications and source records attributed to Borbely, S..

3 recordsLinked to original sources

Dual thalamic drive defines the intra-amygdala wiring complexity

The amygdala plays a key role in affective behaviors by integrating incoming signals and conveying them towards subcortical output regions. Current models suggest a serial information flow within the amygdala from the lateral and basolateral towards the central subnuclei driven by incoming thalamic and cortical excitation. However, due to the lack of universally accepted parcellation principles, the precise connectivity and thus, the signal propagation within the circuit remain debated. Using a molecular-based parcellation, our subnucleus-specific anatomical and electrophysiological mapping revealed a previously overlooked complexity in the intra-amygdala wiring pattern in mice. Specifically, the intra-amygdala signal transfer relies on separate lateral thalamus-driven routes via the lateral subnucleus mostly bypassing the anterior basolateral and centrolateral subnuclei. In contrast, the anterior basolateral nucleus, innervated by the dorsal midline thalamus, supplies mostly extra-, but not intra-amygdala routes. We also demonstrated that a similar dual thalamo-cortico-amygdala organization exists in the human brain. Collectively, our findings identified unconventional amygdala wiring principles challenging the traditional serial lateral-basolateral-central stream model which can redefine our understanding of behaviorally relevant intra-amygdala computations.

neuroscience↗

A thalamic circuit mechanism for stress-dependent modulation of REM sleep

Rapid eye movement (REM) sleep, a brain state critical for sleep quality and cortical cognition, is tightly controlled by brainstem circuits and highly sensitive to stress. Yet, how these systems interact to regulate REM sleep and its associated forebrain rhythms remains elusive. Here, we identify a thalamic hub that conveys medullary REM-promoting signals, and integrates stress inputs to regulate REM sleep. A subpopulation of paraventricular thalamic neurons that collaterally project to the cortex and nucleus accumbens (PVT[->]NAc) selectively responds to activation of medulla REM-promoting neurons, and bidirectionally modulates REM-associated theta oscillations in an activity-dependent manner. Their low-frequency activation promotes theta rhythms during REM sleep, while high-frequency activation suppresses them, mirroring the neuronal signatures of acute and chronic stress, respectively. Distinct patterns of PVT[->]NAc neurons underlie the bidirectional stress modulation of REM sleep, partly by differentially engaging prefrontal microcircuits via their collateral projections. Together, our findings uncover a thalamic integrative hub that couples sleep-regulating and stress pathways to adaptively control REM sleep expression.

neuroscience↗

Anti-glutamatergic effects of three lignan compounds: arctigenin, matairesinol and trachelogenin - An ex vivo study on rat brain slices

Arctigenin is a bioactive dibenzylbutyrolactone-type lignan exhibiting various pharmacological activities. The neuroprotective effects of arctigenin were demonstrated to be mediated via inhibition of AMPA/KA type glutamate receptors in the somatosensory cortex of the rat brain. The aim of this study was to compare the effects of arctigenin with matairesinol and trachelogenin on synaptic activity in ex vivo rat brain slices. Arctigenin, matairesinol and trachelogenin were isolated from Arctium lappa, Centaurea scabiosa and Cirsium arvense, respectively, and applied on brain slices via perfusion medium at the concentration range of 0.5-40 M. The effects of the lignans were examined in the CA1 hippocampus and the somatosensory cortex by recording electrically evoked field potentials. Arctigenin and trachelogenin caused a significant dose-dependent decrease in the amplitude of hippocampal population spikes (POPS) and the slope of excitatory postsynaptic potentials (EPSPs), whereas matairesinol (1 M and 10 M) decreased EPSP slope but had no effect on POPS amplitude. Trachelogenin effect (0.5 M, 10 M, 20 M) was comparable to arctigenin (1 M, 20 M, 40 M) (p > 0.05). In the neocortex, arctigenin (10 M, 20 M) and trachelogenin (10 M) significantly decreased the amplitude of evoked potential early component, while matairesinol (1 M and 10 M) had no significant effect (p>0.05). The results suggest that trachelogenin and arctigenin act via inhibition of AMPA/KA receptors in the brain and trachelogenin has a higher potency than arctigenin. Thus, trachelogenin and arctigenin could serve as lead compounds in the development of alternative neuroprotective drugs.

pharmacology and toxicology↗